These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28803934)

  • 1. Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.
    O'Donnell JN; Rhodes NJ; Miglis CM; Catovic L; Liu J; Cluff C; Pais G; Avedissian S; Joshi MD; Griffin B; Prozialeck W; Gulati A; Lodise TP; Scheetz MH
    Int J Antimicrob Agents; 2018 Feb; 51(2):239-243. PubMed ID: 28803934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.
    Pang HM; Qin XL; Liu TT; Wei WX; Cheng DH; Lu H; Guo Q; Jing L
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4203-4213. PubMed ID: 29028077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
    O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Miglis CM; Joshi MD; Venkatesan N; Pais G; Cluff C; Lamar PC; Briyal S; Day JZ; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
    Avedissian SN; Pais GM; O'Donnell JN; Lodise TP; Liu J; Prozialeck WC; Joshi MD; Lamar PC; Becher L; Gulati A; Hope W; Scheetz MH
    J Antimicrob Chemother; 2019 Aug; 74(8):2326-2334. PubMed ID: 31065686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
    Rhodes NJ; Prozialeck WC; Lodise TP; Venkatesan N; O'Donnell JN; Pais G; Cluff C; Lamar PC; Neely MN; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5742-51. PubMed ID: 27431226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
    Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
    BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
    Pais GM; Liu J; Avedissian SN; Hiner D; Xanthos T; Chalkias A; d'Aloja E; Locci E; Gilchrist A; Prozialeck WC; Rhodes NJ; Lodise TP; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
    J Antimicrob Chemother; 2020 May; 75(5):1228-1236. PubMed ID: 32011685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.
    Ren H; Zhou X; Dai D; Liu X; Wang L; Zhou Y; Luo X; Cai Q
    BMC Nephrol; 2015 Aug; 16():142. PubMed ID: 26283194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
    Tekce BK; Uyeturk U; Tekce H; Uyeturk U; Aktas G; Akkaya A
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):88-94. PubMed ID: 24670880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
    Pais GM; Liu J; Zepcan S; Avedissian SN; Rhodes NJ; Downes KJ; Moorthy GS; Scheetz MH
    Pharmacotherapy; 2020 May; 40(5):438-454. PubMed ID: 32239518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study.
    Carvalho Pedrosa D; Macedo de Oliveira Neves F; Cavalcante Meneses G; Pinheiro Gomes Wirtzbiki G; da Costa Moraes CA; Costa Martins AM; Braga Libório A
    Pediatr Nephrol; 2015 Dec; 30(12):2207-13. PubMed ID: 26248472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries.
    Elmedany SM; Naga SS; Elsharkawy R; Mahrous RS; Elnaggar AI
    J Crit Care; 2017 Aug; 40():171-177. PubMed ID: 28411423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.
    Pavkovic M; Robinson-Cohen C; Chua AS; Nicoara O; Cárdenas-González M; Bijol V; Ramachandran K; Hampson L; Pirmohamed M; Antoine DJ; Frendl G; Himmelfarb J; Waikar SS; Vaidya VS
    Toxicol Sci; 2016 Jul; 152(1):205-13. PubMed ID: 27122240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model.
    Chang J; Pais GM; Engel PL; Klimek P; Marianski S; Valdez K; Scheetz MH
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0127622. PubMed ID: 36648224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Toxicodynamic Effects of Extracellular Hemoglobin After Acute Exposure.
    Baek JH; Yalamanoglu A; Brown RP; Saylor DM; Malinauskas RA; Buehler PW
    Toxicol Sci; 2018 Nov; 166(1):180-191. PubMed ID: 30085279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with acute kidney injury in children receiving vancomycin.
    Sinclair EA; Yenokyan G; McMunn A; Fadrowski JJ; Milstone AM; Lee CK
    Ann Pharmacother; 2014 Dec; 48(12):1555-62. PubMed ID: 25186624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.